• No results found

Neuromodulation and urodynamics in lower urinary tract symptoms Groenendijk, P.M.

N/A
N/A
Protected

Academic year: 2021

Share "Neuromodulation and urodynamics in lower urinary tract symptoms Groenendijk, P.M."

Copied!
8
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Groenendijk, P. M. (2008, December 9). Neuromodulation and urodynamics in lower urinary tract symptoms. Retrieved from

https://hdl.handle.net/1887/13341

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/13341

Note: To cite this publication please use the final published version (if

applicable).

(2)

Neuromodulation and Urodynamics in Lower Urinary Tract Symptoms

Pieter M. Groenendijk

(3)

Printed by Quantes BV, Rijswijk, The Netherlands Layout by Charissa Boek

Copyright © P.M. Groenendijk, Rijswijk, The Netherlands, 2008

(4)

Neuromodulation and Urodynamics in Lower Urinary Tract Symptoms

Proefschrift

ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van de Rector Magnificus prof. mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op dinsdag 9 december 2008

klokke 11.15 uur door

Pieter Marinus Groenendijk geboren te Nootdorp in 1965

(5)

Overige leden Prof. Dr. Ph.E.V.A. van Kerrebroeck (AZ Maastricht)

Dr. R.C.M. Pelger

Prof. J. Zwartendijk

The publication of this thesis was generously supported by: Medtronic International Trading Sarl, Medtronic Trading Netherlands BV and Raad van Bestuur Reinier de Graaf Groep Delft/Voorburg,

Additional support was granted by Abbott BV, Astellas Pharma BV, Astra Tech BV, AstraZeneca BV, Bayer BV, GlaxoSmithKline, Ipsen Pharmaceutica BV, Lamepro BV, MMS International, Novartis Pharma BV, Olympus Nederland BV, Pfizer BV, G. Pohl

Boskamp Gmbh&Co. Sanofi Aventis, SCA Health Care and Uroplasty BV

Neuromodulation and urodynamics in lower urinary tract symptoms. Thesis University Leiden, Leiden, the Netherlands, including a Dutch summary.

© 2008 All rights reserved, including the right of reproduction in whole or in part in any form.

(6)

”Let’s go balistic”

Voor mijn ouders

(7)
(8)

Contents

Introduction Aim of the thesis 10 Neuromodulation treatment modalities 11

Bladder and urethral anatomy 22

Chapter 1 Urethral instability: current pathophysiological concept

(in press for publication in Urologia Internationalis) 32

Chapter 2 Five-year follow-up after sacral neuromodulation (SNM):

single center experience (Neuromodulation, 2007) 46

Chapter 3 Urodynamic evaluation of sacral neuromodulation for urge

urinary incontinence (BJU Int, 2008) 60

Chapter 4 Clinical and urodynamic assessments of the mode of action of sacral nerve stimulation (in New perspectives in sacral nerve

stimulation, 2002) 72

Chapter 5 Urethral instability and sacral nerve stimulation: a better

parameter to predict the efficacy? (J Urol, 2007) 86

Chapter 6 Functional extracorporeal magnetic stimulation as a treatment

for female urinary incontinence: ‘the chair’ (BJU Int, 2004) 98

Chapter 7 Extracorporeal Magnetic Innervation therapy: assessment of clinical efficacy in relation to urodynamic parameters

(Scand J Urol Nephrol, 2008) 108

Summary 120

Samenvatting 123 List of publications 126

Nawoord 129

Curriculum vitae 130

Referenties

GERELATEERDE DOCUMENTEN

In 74 patients with complaints of urge urinary incontinence, urgency/frequency, stress incontinence, mixed inconti- nence and defecation problems, no change in pelvic floor

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an

The prevalence of URI in patients with lower urinary tract symptoms is considerably higher (up to 84%) and depends on patient selection, the technique used to measure urethral

Objective: We studied long term clinical efficacy of sacral neuromodulation (SNM) therapy in patients with refractory urgency incontinence (UI), urgency/frequency (UF) and

Based on clinical data, 33 of 54 (61%) patients with UI and DO still present after 6 months showed an improvement of > 50% in the reduction of incontinence episodes at the

The mode of action of SNS, based on our clinical and urodynamic observations, appears to be a primary afferent effect via pelvic and pudendal nerve fibres, resulting in a motor

and Groen, J.: Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using